Authors


Ruopeng An, PhD

Latest:

Impact of a Patient Incentive Program on Receipt of Preventive Care

Patient financial incentives are a potential mechanism to improve health. In a South African health plan, a patient incentive program is associated with increased prevention.


Ashok M. Patel, MD

Latest:

Flunking Asthma? When HEDIS Takes the ACT

Asthma control, rather than compliance with the HEDIS asthma measure, is the most useful quality indicator of asthma care.


Cardella Leak, PhD, MPH

Latest:

A Mid-South Chronic Disease Registry and Practice-Based Research Network to Address Disparities

The authors report the experience of one of the first Southern US communities to develop a comprehensive health care data repository for tracking processes and outcomes of care and identifying areas of greatest need.



Yong Li, PhD

Latest:

Transition-to-Dialysis Planning, Health Care Use, and Mortality in End-Stage Renal Disease

A planned transition to dialysis was associated with improved outcomes and lower mortality. These findings may inform care coordination policies for end-stage renal disease.







Zhi Wang, PhD

Latest:

Having a Consistent HIV Health Care Provider and HIV-Related Clinical Outcomes

The study examined the association of having a consistent HIV health care provider with related clinical outcomes, with an emphasis on a long-term physician-patient relationship.



Lisa J. McGarry, MPH

Latest:

Cost-Effectiveness of Laparoscopic Gastric Banding and Bypass for Morbid Obesity

Laparoscopic adjustable gastric banding and gastric bypass are cost-effective treatments for morbid obesity compared with no treatment.


Helen Guo, BSc, MSc

Latest:

Evaluation of Electronic Medical Record Administrative Data Linked Database (EMRALD)

The combination of electronic medical record data and administrative data provides the fullest picture of patient health histories.


Vera J. Suman, PhD

Latest:

Development of a Multidisciplinary, Multicampus Subspecialty Practice in Endocrine Cancers

The development of subspecialty tumor groups for uncommon malignancies represents an effective approach to building experience, increasing patient volumes and referrals, and fostering development of increased therapeutic options and clinical trials for patients afflicted with otherwise historically neglected cancers.


Joseph W. Sakshaug, PhD

Latest:

The Association Among Medical Home Readiness, Quality, and Care of Vulnerable Patients

The characteristics of patients who visit practices that are ready versus unready for the patient-centered medical home differ in important ways.




Stacey McCullough, PharmD

Latest:

Pharmacy's Changing Role as Cancer Care Transitions From Infused to Oral Therapies

The advent of oral oncolytics has changed the pharmacy's role in patient care beyond compounding infusions. Pharmacy staff now routinely engage patients, assessing adherence and tolerance to therapy as well as helping them navigate prescription benefits.




Marie Helweg-Larsen, PhD

Latest:

A Randomized Controlled Trial of Negative Co-Payments: The CHORD Trial

This study extends value-based insurance design concepts in testing the impact on blood pressure control of rewards that provided negative co-payments for blood pressure medication.


Daniel Varga, MD

Latest:

Impact of a Scalable Care Transitions Program for Readmission Avoidance

The 30-day readmission risk was reduced 25% by a collaborative program model employing discharge planning and telephonic follow-up for high-risk patients with CMS penalty diagnoses.






Carol Addy, MD, MMSc

Latest:

Value-Based Health Insurance Design: How Much Does Socioeconomic Status Matter?

Socioeconomic status may significantly influence enrollee response to value-based benefit design approaches. Evaluating the association of wage status with claims experience may yield actionable insights.



L. Patrick James, MD

Latest:

Genetic Oncology Testing Is Complex, but Coverage and Reimbursement Don't Have to Be

The chief clinical officer of health plans and policy for Quest Diagnostics discusses how payers can assess the value of genetic testing in oncology.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo